Vendor, Chicago, IL
Meabco Inc.
UEI YJK6BN3N9DE7, CAGE 8C2F1
1 award and -$96,749 obligated between September 4, 2026 and September 4, 2026, 100% under full and open competition, against 7.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | -$96,749 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93020C00004Definitive Contract, September 4, 2026, Full and Open Competition, 7 offers | National Institutes of Health NiaidNational Institutes of Health | To Administratively De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in PreparatiNAICS 541714, PSC AN12 | -$96,749 |
- Places of performance
- Illinois
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 1 across 1 awards